DNA. Antibodies. Cell lines.
discoCHO
Transient expression in CHO-K1
Delivering the speed needed for lead optimization and the critical quality attributes of our miCHO manufacturing cell line. Available as an ATUM service or via licensing.
We think of projects more as a collaboration than services. We combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and sequence optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.
ATUM in the World
February 18, 2025
Developing stable cell lines is a complex, time-intensive process involving numerous steps.
July 9, 2024
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
February 22, 2024
Mitigating the aggregation challenge in immunocytokine production: Strategies during cell line development and purification optimization
January 4, 2024
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
December 1, 2021
Will we be protected from COVID-19’s omicron variant? Bay Area researchers sprint to find out
